Farr Miller & Washington’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-48,164
Closed -$829K 142
2018
Q3
$829K Sell
48,164
-10,815
-18% -$161K 0.07% 73
2018
Q2
$822K Sell
58,979
-5,107
-8% -$86.3K 0.07% 69
2018
Q1
$982K Buy
+64,086
New +$916K 0.09% 69

Other funds holding PGEN

Farr Miller & Washington's PGEN Position: Q4 2018 in Review

Farr Miller & Washington sold out of Precigen (PGEN) in Q4 2018, closing a stake of 48,164 shares — an estimated $829K sold.

Farr Miller & Washington first reported a position in PGEN in Q1 2018 and held it in 3 quarters. The position peaked at $982K in Q1 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q4 2018.

  • Farr Miller & Washington reported no remaining Precigen position as of Q4 2018 after selling out during the quarter.
  • Farr Miller & Washington sold 48,164 Precigen shares in Q4 2018, an estimated $829K.
  • Farr Miller & Washington first reported a position in Precigen in Q1 2018 and held it in 3 quarters.
  • Farr Miller & Washington's Precigen position peaked at $982K in Q1 2018.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q4 2018.

Based on Farr Miller & Washington's 13F filing for Q4 2018, filed 14 Feb 2019.